Zai Lab Limited
ZLAB
|
$15.66
3.57%
3.45%
430K
|
Health Technology
(0.0% 1d) (-1.8% 1m) (-54.8% 1y) (0.0% 2d) (3.6% 3d) (11.3% 7d) (-8.12% volume)
Earnings Calendar:
Market Cap: $ 1,553,608,915
http://www.zailaboratory.com
Sec Filling | Patents | 692 employees
(China (Mainland)) Zai Lab Ltd. is a biopharmaceutical company. It engages in the discovering, licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need in the fields of oncology, infectious and autoimmune diseases. The company's products include Zejula and Optune. Zai Lab was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
china autoimmunity urea
add to watch list Paper trade email alert is off
Press-releases
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
nuzyra pre-clinical pharmaceuticals global
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
Published: 2024-04-15 (Crawled : 15:00) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: -1.33%
H: 2.66%
C: 0.57%
first financial results
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs
Published: 2024-04-02 (Crawled : 00:00) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: -2.33%
H: 0.0%
C: 0.0%
ongoing global meeting key
Zai Lab Announces Participation in March Investor Conference
Published: 2024-03-06 (Crawled : 17:00) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 3.17%
H: 4.0%
C: 1.49%
conference
Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 8.34%
H: 0.65%
C: -1.1%
financial results
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.47 4.22% 4.05% 690
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $375.0 -0.02% -0.02% 200K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
Zai Lab Announces The New England Journal of Medicine Publication Demonstrating Durable Clinical Activity of Repotrectinib in Patients with Advanced ROS1 Fusion-Positive NSCLC
Published: 2024-01-10 (Crawled : 00:00) - biospace.com/
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.16%
H: 0.09%
C: -1.05%
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 0.38%
H: 1.24%
C: -2.14%
publication advanced
Zai Lab Announces Participation in January Investor Conference
Published: 2023-12-19 (Crawled : 13:30) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 2.83%
H: 1.23%
C: -0.84%
conference
Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List
Published: 2023-12-13 (Crawled : 10:00) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 4.67%
H: 10.29%
C: 6.86%
vyvgart first drug
Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug List
Published: 2023-12-13 (Crawled : 15:30) - biospace.com/
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 4.67%
H: 10.29%
C: 6.86%
nuzyra drug pharmaceuticals
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10